Vigilance is our key for patient safety. Patient safety is our primary and main objective!
Statistics & Data Analysis
We choose the right statistical tool and computational model to analyse your data.
We streamline clinical operations to provide efficacious solutions for complex projects.
Dr. Shereen Aly
MD, PhD - CEO and Founder
“I get satisfaction from so many different aspects of my career including research, studying science, teaching and taking care of patients. But, if I were forced to say what I enjoy most, it's the process of telling a scientific research story.”
Physician and researcher, Shereen received a master and doctorate degree in critical care medicine in 2007 and a master degree in pharmacovigilance and epidemiology in 2018. She is a true pioneer in her field, and author of many scientific publications. Her career is a fast-paced balancing act between research and medicine. She thrives on this contrast between the ICU and evidence based research. Both feed her "high-stakes, high-intensity personality type" in different ways: one is physical and calls for quick decision-making; the other is intellectual and requires a long vision. Establishing this balance has demanded Shereen’s unwavering dedication, often in the face of both professional and personal obstacles. Not only is she an accomplished physician and gravitated towards posts in academic units but also she is a very talented researcher and drug safety consultant as well. She turned to clinical research as the major focus of her career, and thrived in research environments and found clinical and research invigorating and rewarding. It is not only intellectually stimulating but also emotionally rewarding.
Contact Dr. Aly:
Dr. Bassem Toeama
MD, PhD - CEO and Founder
Bassem graduated in medicine and has worked in clinical medicine as an oncologist, in academia, and in pharmaceutical industry over the past 20 years. His experience has been primarily in oncology, pharmacovigilance, clinical research, and lab research. He holds an MSc degree in Experimental Therapeutics at the University of Oxford, UK and an MSc degree in Experimental Medicine at McGill University, Canada. He is a PhD candidate in health technology assessment at the University of Toronto, Canada. Bassem is a pharmacovigilance consultant, a clinical research instructor, a graduate teaching assistant, and a lead medical writer at the University of Toronto, Canada. Bassem’s areas of research are health technology assessment, decision analysis, and benefit risk assessment.
Contact Dr. Toeama: